Skip to main content
Clinical Trials/CTRI/2024/05/066907
CTRI/2024/05/066907
Not Yet Recruiting
Phase 2

A Clinical and In-Silico Study to Assess the Efficacy of Virechana Followed by Oral Medications and Analysis of Outcomes of Hamsapathyadi Kashayam on THRa And THRß In Hypothyroidism - NI

All India Institute of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E039- Hypothyroidism, unspecified
Sponsor
All India Institute of Ayurveda
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients between 21 to 60 years of age of either sex.
  • 2\.Patients with the symptomatology of hypothyroidism and elevated TSH.
  • 3\.Hypothyroid patients with associated Dyslipidemias \[13]\[14].
  • 4\.Patients willing to participate in the trial.

Exclusion Criteria

  • 1\.Conditions contraindicated for Snehana and Virechana Procedure.
  • 2\.Any other thyroid pathology or any other endocrine disorders like DM, PCOS, Hyperparathyroidism, etc.
  • 3\.Pregnant females and breastfeeding mothers.
  • 4\.Any other major systemic illnesses like CAD, IHD, Arrhythmias, Vulvar Heart disease, CVA, Abnormal BP, Aortic Aneurysm, etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials